Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Behavioral Health topic
No spam. Unsubscribe anytime.
Committee backs $30.2M amendment to UCSF opioid‑treatment contract through 2027
Summary
The committee recommended that the Board approve a second amendment to an existing Department of Public Health contract with UCSF Division of Substance Abuse Medicine, increasing the agreement by $30.2M and extending the term six years to continue medication‑assisted treatment and outreach services.
The committee voted Jan. 27 to forward to the full Board a resolution approving Amendment No. 2 to the Department of Public Health’s agreement with the Regents of the University of California at San Francisco, Division of Substance Abuse Medicine. The amendment increases the agreement by $30.2 million to a total not‑to‑exceed amount of $44.2 million and extends the contract term through June 30, 2027.
Michelle Ruggles and Jim Stilwell (DPH) described the services covered by the contract, which include medication‑assisted treatment through OTP (opiate treatment outpatient programs), office‑based buprenorphine induction clinics, and related outpatient services. DPH reported 94 unduplicated clients served in fiscal year 2019–20 for the contract and provided a demographic breakdown in a late supplemental attachment: 29% African American, 2% Asian, and 14% Latinx in the reported sample. Supervisors pressed for ongoing race‑equity reporting and numbers served; DPH agreed to include demographic reporting in regular updates and consider BLA coordination.
Committee members also asked about the program’s ability to scale to meet fentanyl‑related overdose trends; DPH said expansion can be supported in part by Medi‑Cal billing and by contingency built into baseline funding, and that larger proposals are in development to address overdose crises across the system. The committee forwarded the amendment to the full Board with a positive recommendation (three ayes).
